OSTEOPONTIN-REGULATED CHANGES IN THE MAST CELL POPULATION ASSOCIATED WITH BREAST CANCER
DOI:
https://doi.org/10.15407/exp-oncology.2024.03.209Keywords:
breast cancer, mast cells, osteopontin, prognosisAbstract
Background. The development of breast cancer (BCa) is largely determined by the characteristics of the tumor microenvironment (ТМЕ), which undergoes significant changes during the progression of the disease. Mast cells (MCs) are among the least studied components of the TME. The aim of the work was to investigate the relationship between the density of infiltration and the functional activity of MCs with indicators of osteopontin (OP) expression in BCa tissue. Materials and Methods. The study was conducted on the postoperative material of 15 patients with fibroadenoma and 78 patients with stage I—II BCa. MCs in the tissue of benign and malignant breast tumors were detected by a histochemical method using toluidine blue. The functional activity of MCs was calculated by the degranulation index. The OP expression in tumor tissue was assessed by the immunohistochemical method. Results. The density of MCs infiltration and their functional activity are associated with such indicators of BCa malignancy as tumor size, lymph node involvement, tumor grade, molecular subtype, proliferative activity, and PR- and HER2/neu-expression status. A high expression of OP in the stromal component of BCa is associated with the growth of the tumoral MCs population, metastatic lesions in regional lymph nodes, and a low differentiation grade of the tumors. In addition, OP is involved in the regulation of MCs in the tissue of the luminal B and basal molecular BCa subtypes. The level of OP expression in the parenchymal component of BCa is associated with the number of infiltrated MCs in the presence of metastatic lesions of regional lymph nodes. Conclusions. The identified relationship of OP expression level with the topology and functional activity of MCs in BCa tissue, depending on the clinical status of patients, indicates the prospects for their use in predicting the aggressiveness of the tumor process.
References
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229263. https://doi.org/10.3322/caac.21834
Chekhun V, Martynyuk О, Lukianova Y, et al. Features of breast cancer in patients of young age: search for diagnosis optimization and personalized treatment. Exp Oncol. 2023;45(2):139150. doi: 10.15407/exponcology.2023.02.139
American Cancer Society: Atlanta. Breast Cancer Facts and Figures 2017–2018; GA, USA, 2017.
Yang J, Bahcecioglu G, Zorlutuna P. The Extracellular matrix and vesicles modulate the breast tumor microenviron ment. Bioengineering (Basel). 2020;7(4):124. https://doi.org/10.3390/bioengineering7040124
Tan Z, Kan C, Sun M, et al. Mapping breast cancer microenvironment through singlecell omics. Front Immunol.
;13:868813. https://doi.org/10.3389/fimmu.2022.868813
Ribatti D, Annese T, Tamma R. Controversial role of mast cells in breast cancer tumor progression and angiogenesis.
Clin Breast Cancer. 2021;21(6):486491. https://doi.org/10.1016/j.clbc.2021.08.010
Maciel TT, Moura IC, Hermine O. The role of mast cells in cancers. F1000Prime Rep. 2015;7:09. https://doi. org/10.12703/P709
Sacks D, Baxter B, Campbell В, et al. Multisociety Consensus Quality Improvement Revised Consensus State ment for Endovascular Therapy of Acute Ischemic Stroke. Int J Stroke. 2018;13(6):612632. https://doi. org/10.1177/1747493018778713
Dyduch G, Kaczmarczyk K, Okoń K. Mast cells and cancer: enemies or allies? Pol J Pathol. 2012;63(1):17.
Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18(5):693704. https://doi.org/10.1038/nm.2755
Eissmann MF, Buchert M, Ernst M. IL33 and mast cells – the key regulators of immune responses in gastrointestinal cancers? Front Immunol. 2020;11:1389. https://doi.org/10.3389/fimmu.2020.01389
Tiwari A, Trivedi R, Lin SY. Tumor microenvironment: barrier or opportunity towards effective cancer therapy.
J Biomed Sci. 2022;29(1):83. https://doi.org/10.1186/s12929022008663
Zadvornyi T, Lukianova N, Borikun T, et al. Mast cells as a tumor microenvironment factor associated with the ag gressiveness of prostate cancer. Neoplasma. 2022;69(6):14901498. https://doi.org/10.4149/neo_2022_221014N1020
Lamort AS, Giopanou I, Psallidas I, et al. Osteopontin as a link between inflammation and cancer: the thorax in the spotlight. Cells. 2019;8(8):815. https://doi.org/10.3390/cells8080815
Linder DP, Poberiĭ IA, Rozkin MIa, et al. Morphometric analysis of a mast cell population. Arkh Patol. 1980;42(6):6064.
McClelland RA, Wilson D, Leake R, et al. A multicentre study into the reliability of steroid receptor immunocy tochemical assay quantification. British Quality Control Group. Eur J Cancer. 1991;27(6):711715. https://doi. org/10.1016/02775379(91)901719
Fedchenko N, Reifenrath J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue a review. Diagn Pathol. 2014;9:221. https://doi.org/10.1186/s1300001402219
Seyed Jafari SM, Hunger RE. IHC Optical density score: a new practical method for quantitative immunohisto chemistry image analysis. Appl Immunohistochem Mol Morphol. 2017;25(1):e12e13. https://doi.org/10.1097/ PAI.0000000000000370
Chekhun V, Pavlova A, Zadvornyi T, et al. Expression of SPP1 and SPARC genes in tumor tissue of patients with breast cancer. Exp Oncol. 2024;46(1):1321. https://doi.org/10.15407/exponcology.2024.01.013
Kashiwase Y, Morioka J, Inamura H, et al. Quantitative analysis of mast cells in benign and malignant breast le sions. Immunohistochemical study on formalinfixed, paraffinembedded tissues. Int Arch Allergy Immunol. 2004;134(3):199205. https://doi.org/10.1159/000078766
Löfdahl B, Ahlin C, Holmqvist M, et al. Inflammatory cells in nodenegative breast cancer. Acta Oncol. 2012;51(5):680 686. https://doi.org/10.3109/0284186X.2011.652737
Fakhrjou A, NaghaviBehzad M, Montazeri V, et al. The relationship between histologic grades of invasive carcinoma of breast ducts and mast cell infiltration [published correction appears in South Asian J Cancer. 2016;5(3):166. doi: 10.4103/2278330X.187594]. South Asian J Cancer. 2016;5(1):57. https://doi.org/10.4103/2278330X.179699
Glajcar A, Szpor J, Pacek A, et al. The relationship between breast cancer molecular subtypes and mast cell popula tions in tumor microenvironment. Virchows Arch. 2017;470(5):505515. https://doi.org/10.1007/s0042801721035
Pyla RD, Potekar RM, Patil VS, et al. Quantitative mast cell analysis and hormone receptor study (ER, PR and HER2/neu) in invasive carcinoma of breast. Indian J Pathol Microbiol. 2020;63(2):200204. https://doi.org/10.4103/IJPM.IJPM_155_19
Xiang M, Gu Y, Zhao F, et al. Mast cell tryptase promotes breast cancer migration and invasion. Oncol Rep.
;23(3):615619. https://doi.org/10.3892/or_00000676
Amini RM, Aaltonen K, Nevanlinna H, et al. Mast cells and eosinophils in invasive breast carcinoma. BMC Cancer.
;7:165. https://doi.org/10.1186/147124077165
Keser SH, Kandemir NO, Ece D, et al. Relationship of mast cell density with lymphangiogenesis and prognostic pa rameters in breast carcinoma. Kaohsiung J Med Sci. 2017;33(4):171180. https://doi.org/10.1016/j.kjms.2017.01.005
Zadvornyi T, Lukianova N, Borikun T, et al. Mast cells as a tumor microenvironment factor associated with the ag gressiveness of prostate cancer. Neoplasma. 2022;69(6):14901498. https://doi.org/10.4149/neo_2022_221014N1020
Lukianova N, Zadvornyi T, Kashuba E, et al. Expression of markers of bone tissue remodeling in breast cancer and prostate cancer cells in vitro. Exp Oncol. 2022;44(1):3946. https://doi.org/10.32471/exponcology.23128852.vol44 no1.17354
Baiula M, Spampinato S, Gentilucci L, et al. Novel ligands targeting α4β1 integrin: therapeutic applications and per spectives. Front Chem. 2019; 7:489. https://doi.org/10.3389/fchem.2019.00489
Abonia JP, Hallgren J, Jones T, et al. Alpha4 integrins and VCAM1, but not MAdCAM1, are essential for re cruitment of mast cell progenitors to the inflamed lung. Blood. 2006;108(5):15881594. https://doi.org/10.1182/ blood200512012781
Nagasaka A, Matsue H, Matsushima H, et al. Osteopontin is produced by mast cells and affects IgEmediated de granulation and migration of mast cells. Eur J Immunol. 2008;38(2):489499. https://doi.org/10.1002/eji.200737057
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Experimental Oncology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.